Skip to main content

HHS: Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder

Source
Federal Register
Date
Apr 28, 2021
Summary
Notice from the U.S. Department of Health and Human Services (HHS) issuing practice guidelines allowing eligible practitioners to treat up to 30 patients with opioid use disorder (OUD) using buprenorphine without having to meet certain federal certification requirements related to training, counseling, and other ancillary services. This guidance is intended to expand access to buprenorphine for OUD treatment. This guidance is effective April 28, 2021.
Tagged as
Access · Health occupations · Illicit drug use · Licensure and certification of health professionals · Policy · Prescription drug misuse · Substance use and misuse